To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Epidural Nalbuphine Vs Dexmedetomidine For Lower Limb Orthopedic Surgeries

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
May 2024

Epidural Nalbuphine Vs Dexmedetomidine For Lower Limb Orthopedic Surgeries

Vol: 306| Issue: 5| Number:116| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Epidural nalbuphine versus dexmedetomidine as adjuvants to bupivacaine in lower limb orthopedic surgeries for postoperative analgesia: a randomized controlled trial.

BMC Anesthesiol . 2023 Dec 6;23(1):401.

Contributing Authors:
MSE Farmawy SMS Mowafy RA Wahdan

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

72 patients with lower limb orthopedic surgeries were randomized to receive epidural bupivacaine with either nalbuphine (n=24), dexmedetomidine (n=24), or saline as a control (n=24). The primary outcome of interest was the duration of postoperative analgesia. Secondary outcomes included the onset of epidural analgesia, sedation scores, patient satisfaction, adverse effects, pain on a Visual Analog...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue